Parameter | All patients | COPD | RD | NMD | OHS/OL |
---|---|---|---|---|---|
N | 231 | 98 | 49 | 15 | 69 |
Gender (f/m) | 86/145 | 28/70 | 28/21 ** | 5/10 | 25/44 |
Age (yrs) | 62.9 ± 10.2 | 64.6 ± 8.2 | 63.2 ± 12.0 | 62.8 ± 7.1 | 60.3 ± 11.4 *** |
BMI (kg/m2) | 33.2 ± 9.9 | 29.4 ± 7.0 | 29.3 ± 5.6 | 28.9 ± 10.0 | 42.3 ± 9.9 *** |
Ventilator use (h/d) | 6.76 ± 2.52 | 6.70 ± 2.81 | 7.16 ± 2.11 | 7.20 ± 2.37 | 6.47 ± 2.39 |
Duration of HMV (months) | 28.9 ± 8.8 | 29.6 ± 28.3 | 45.2 ± 36.9 * | 27.4 ± 25.5 | 32.1 ± 25.2 |
Hb (g/dL) | 13.7 ± 1.6 | 13.9 ± 1.7 | 13.7 ± 1.5 | 13.7 ± 1.2 | 13.5 ± 1.7 |
Leukocyte number (103/μL) | 8.97 ± 3.13 | 10.1 ± 3.5 | 7.5 ± 2.3 *** | 7.2 ± 2.5* | 8.8 ± 2.6 * |
Heart disease, N (%) | 65 (28.1) | 29 (29.6) | 11 (22.4) | 5 (33.3) | 20 (29.0) |
Diabetes, N (%) | 41 (17.7) | 20 (20.4) | 4 (8.1) | 2 (13.3) | 15 (21.7) |
Hyperlipidaemia, N (%) | 27 (11.7) | 11 (11.2) | 7 (14.2) | 1 (6.7) | 8 (11.6) |
Hypertension, N (%) | 121 (52.4) | 42 (42.8) | 22 (44.9) | 7 (46.7) | 50 (72.5) *** |
FEV1 (L) | 1.25 ± 0.71 | 0.85 ± 0.26 | 0.89 ± 0.34 | 1.25 ± 0.58 * | 2.08 ± 0.68 *** |
FEV1 (%pred) | 48.7 ± 22.3 | 32.7 ± 8.7 | 44.0 ± 14.6 ** | 50.3 ± 24.0 ** | 73.9 ± 17.1 *** |
FEV/IVC (%) | 61.9 ± 17.8 | 45.8 ± 9.2 | 74.3 ± 9.9 *** | 87.4 ± 17.2 *** | 70.3 ± 11.4 *** |
IVC (L) | 2.05 ± 0.95 | 1.91 ± 0.55 | 1.19 ± 0.44 *** | 1.44 ± 0.66 ** | 2.98 ± 0.94 *** |
IVC (%pred) | 70.0 ± 21.2 | 56.3 ± 13.9 | 48.4 ± 16.5 ** | 46.2 ± 22.6 * | 82.8 ± 16.3 *** |
pH | 7.42 ± 0.04 | 7.42 ± 0.03 | 7.42 ± 0.04 | 7. 43 ± 0.03 | 7.43 ± 0.04 |
PaO2 (mmHg) | 68.0 ± 16.0 | 66.8 ± 16.2 | 71.1 ± 18.1 | 69.2 ± 19.1 | 67.2 ± 13.3 |
PaCO2 (mmHg) | 44.2 ± 6.8 | 46.4 ± 6.7 | 44.7 ± 6.6 | 40.5 ± 6.0** | 41.6 ± 6.2 *** |
BE (mmol/L) | 3.93 ± 3.04 | 4.76 ± 3.33 | 3.84 ± 2.57 | 2.86 ± 2.06* | 3.06 ± 2.81 ** |